SB 1219 — Missouri
Modifies provisions relating to distributors of hypodermic needles
Missouri legislative agenda & upcoming votes Missouri session calendar
Summary
SB 1219 - Under this act, any entity registered with the Department of Health and Senior Services that possesses, distributes, or delivers hypodermic needles or syringes for the purposes of operating a syringe exchange program or otherwise mitigating health risks associated with unsterile injection drug use shall be exempt from the offense of unlawful distribution, delivery, or sale of drug paraphernalia, if such entity is not located within 500 feet of a school building, as well as the offense of unlawful manufacturing with intent to deliver drug paraphernalia.
This act is identical to SB 472 (2025), SB 997 (2024), SB 623 (2023), provisions in CCS/HCS/SS/SB 690 (2022), and CCS#2/HCS/SS/SB 64 (2021), substantially similar to HB 1486 (2020), SB 668 (2020), HCS/SS/SB 580 (2020), and HCS/HB 168 (2019), and similar to SCS/HB 1620 (2019).
SARAH HASKINS
- SB 1219 is a bill in the Missouri Senate, 2026 session, introduced December 1, 2025.
- Sponsored by Patty Lewis.
- Current status: introduced.
- Most recent action (January 27, 2026): Second Read and Referred S Families, Seniors and Health Committee.
- Subjects: Drugs and Controlled Substances, Health and Senior Services, Department of, Health, Public.
-
State Senator, District 7
Democratic
Contact your legislator about this bill
Bill text & documents
Sponsors
Primary: Patty Lewis
History
- Introduced, completed
- Passed Senate, in progress
- Passed House, not reached yet
- Sent to Governor, not reached yet
- Signed into law, not reached yet
- Senate Prefiled
- Senate S First Read
- Senate Second Read and Referred S Families, Seniors and Health Committee Latest